Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure

Heart Rhythm

Volumn 4, Issue 8, 2007, Pages 999-1005

  Watanabe, Eiichi ^a   Arakawa, Tomoharu ^a   Uchiyama, Tatsushi ^a   Tong, MaoQing ^a   Yasui, Kenji ^b   Takeuchi, Hiroshi ^c   Terasawa, Toshiaki ^c   Kodama, Itsuo ^b   Hishida, Hitoshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c Business Development Department   (Japan)

Author keywords

Ambulatory electrocardiogram; Arrhythmia; Autonomic nervous system; Circadian rhythm

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART RATE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QT INTERVAL; QT PROLONGATION; REGRESSION ANALYSIS; RR INTERVAL; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SURVIVOR;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34547403306     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.04.019     Document Type: Article

References (32)

1. Pitt B., Poole-Wilson P.A., Segal R., Martinez F.A., Dickstein K., Camm A.J., Konstam M.A., Riegger G., Klinger G.H., Neaton J., Sharma D., and Thiyagarajan B. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
2. Cohn J.N., and Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 (2001) 1667-1675
3. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
4. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., and Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
5. Casolo G., Balli E., Fazi A., Gori C., Freni A., and Gensini G. Twenty-four-hour spectral analysis of heart rate variability in congestive heart failure secondary to coronary artery disease. Am J Cardiol 67 (1991) 1154-1158
6. Panina G., Khot U.N., Nunziata E., Cody R.J., and Binkley P.F. Assessment of autonomic tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability. Am Heart J 129 (1995) 748-753
7. Ponikowski P., Anker S.D., Chua T.P., Szelemej R., Piepoli M., Adamopoulos S., Webb-Peploe K., Harrington D., Banasiak W., Wrabec K., and Coats A.J. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 79 (1997) 1645-1650
8. Ho K.K., Moody G.B., Peng C.K., Mietus J.E., Larson M.G., Levy D., and Goldberger A.L. Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation 96 (1997) 842-848
9. Nolan J., Batin P.D., Andrews R., Lindsay S.J., Brooksby P., Mullen M., Baig W., Flapan A.D., Cowley A., Prescott R.J., Neilson J.M., and Fox K.A. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98 (1998) 1510-1516
10. Galinier M., Pathak A., Fourcade J., Androdias C., Curnier D., Varnous S., Boveda S., Massabuau P., Fauvel M., Senard J.M., and Bounhoure J.P. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 21 (2000) 475-482
11. Saul J.P., Arai Y., Berger R.D., Lilly L.S., Colucci W.S., and Cohen R.J. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 61 (1988) 1292-1299
12. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res 28 (1994) 933-946
13. Pak P.H., Nuss H.B., Tunin R.S., Kaab S., Tomaselli G.F., Marban E., and Kass D.A. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol 30 (1997) 576-584
14. Tomaselli G.F., and Zipes D.P. What causes sudden death in heart failure?. Circ Res 95 (2004) 754-763
15. Murakawa Y., Inoue H., Nozaki A., and Sugimoto T. Role of sympathovagal interaction in diurnal variation of QT interval. Am J Cardiol 69 (1992) 339-343
16. Yamauchi M., Watanabe E., Yasui K., Takeuchi H., Terasawa T., Sawada K., Hishida H., and Kodama I. Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization. Int J Cardiol 103 (2005) 92-97
17. Lepeschkin E., and Surawicz B. The measurement of the QT interval on the electrocardiogram. Circulation 6 (1952) 377-388
18. Lepeschkin E. The U wave of the electrocardiogram. Mod Conc Cardiovasc Dis 38 (1969) 39-45
19. Gilmour Jr. R.F., Otani N.F., and Watanabe M.A. Memory and complex dynamics in cardiac Purkinje fibers. Am J Physiol 272 (1997) H1826-H1832
20. Yi G., Guo X.H., Reardon M., Gallagher M.M., Hnatkova K., Camm A.J., and Malik M. Circadian variation of the QT interval in patients with sudden cardiac death after myocardial infarction. Am J Cardiol 81 (1998) 950-956
21. Brendorp B., Elming H., Jun L., Kober L., Malik M., Jensen G.B., and Torp-Pedersen C. QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation 103 (2001) 1422-1427
22. Vrtovec B., Delgado R., Zewail A., Thomas C.D., Richartz B.M., and Radovancevic B. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 107 (2003) 1764-1769
23. Okin P.M., Devereux R.B., Howard B.V., Fabsitz R.R., Lee E.T., and Welty T.K. Assessment of QT Interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation 101 (2000) 61-66
24. Algra A., Tijssen J.G., Roelandt J., Pool J., and Lubsen J. QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J 70 (1993) 43-48
25. Brooksby P., Batin P.D., Nolan J., Lindsay S.J., Andrews R., Mullen M., Baig W., Flapan A.D., Prescott R.J., Neilson J.M., Cowley A.J., and Fox K.A. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The United Kingdom heart failure evaluation and assessment of risk trial (UK-HEART). Eur Heart J 20 (1999) 1335-1341
26. Crozatier B. Stretch-induced modifications of myocardial performance: from ventricular function to cellular and molecular mechanisms. Cardiovasc Res 32 (1996) 25-37
27. Merri M., Moss A.J., Benhorin J., Locati E.H., Alberti M., and Badilini F. Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings: findings in normal patients and patients with long QT syndrome. Circulation 85 (1992) 1816-1821
28. Tavernier R., Jordaens L., Haerynck F., Derycke E., and Clement D.L. Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared with normal individuals without arrhythmias. Eur Heart J 18 (1997) 994-999
29. Neyroud N., Maison-Blanche P., Denjoy I., Chevret S., Donger C., Dausse E., Fayn J., Badilini F., Menhabi N., Schwartz K., Guicheney P., and Coumel P. Diagnostic performance of QT interval variables from 24-h electrocardiography in the long QT syndrome. Eur Heart J 19 (1998) 158-165
30. Extramiana F., Neyroud N., Huikuri H.V., Koistinen M.J., Coumel P., and Maison-Blanche P. QT interval and arrhythmic risk assessment after myocardial infarction. Am J Cardiol 83 (1999) 266-269
31. Shusterman V., Aysin B., Gottipaty V., Weiss R., Brode S., Schwartzman D., Anderson K.P., and ESVEM Investigators. Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. J Am Coll Cardiol 32 (1998) 1891-1899
32. Zareba W. QT-RR slope: dynamics of repolarization in the risk stratification. J Cardiovasc Electrophysiol 14 (2003) 234-235